EFI
REGN icon

EHP Funds Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

EHP Funds Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-900
Closed -$741K – 227
2023
Q3 		$741K Sell
900
-1,800
-67% -$1.41M 0.35% 77
2023
Q2 		$1.94M Sell
2,700
-1,800
-40% -$1.39M 0.48% 61
2023
Q1 		$3.7M Sell
4,500
-1,200
-21% -$905K 0.72% 29
2022
Q4 		$4.11M Sell
5,700
-300
-5% -$221K 0.78% 41
2022
Q3 		$4.13M Buy
6,000
+200
+3% +$126K 0.84% 38
2022
Q2 		$3.43M Sell
5,800
-600
-9% -$390K 0.57% 66
2022
Q1 		$4.47M Buy
+6,400
New +$4.05M 0.74% 58

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

EHP Funds Inc's REGN Position: Q4 2023 in Review

EHP Funds Inc sold out of Regeneron Pharmaceuticals (REGN) in Q4 2023, closing a stake of 900 shares — an estimated $741K sold.

EHP Funds Inc first reported a position in REGN in Q1 2022 and held it in 7 quarters. The position peaked at $4.47M in Q1 2022. 1,273 funds tracked by Wall St. Rank hold REGN as of Q4 2023.

  • EHP Funds Inc reported no remaining Regeneron Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • EHP Funds Inc sold 900 Regeneron Pharmaceuticals shares in Q4 2023, an estimated $741K.
  • EHP Funds Inc first reported a position in Regeneron Pharmaceuticals in Q1 2022 and held it in 7 quarters.
  • EHP Funds Inc's Regeneron Pharmaceuticals position peaked at $4.47M in Q1 2022.
  • 1,273 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2023.

Based on EHP Funds Inc's 13F filing for Q4 2023, filed 14 Feb 2024.